This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blitvich, B. J.
Right arrow Articles by Beaty, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blitvich, B. J.
Right arrow Articles by Beaty, B. J.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2003, p. 2676-2679, Vol. 41, No. 6
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.6.2676-2679.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Epitope-Blocking Enzyme-Linked Immunosorbent Assays for Detection of West Nile Virus Antibodies in Domestic Mammals

Bradley J. Blitvich,1 Richard A. Bowen,2 Nicole L. Marlenee,1 Roy A. Hall,3 Michel L. Bunning,4,5 and Barry J. Beaty1*

Arthropod-Borne and Infectious Diseases Laboratory, Department of Microbiology, Immunology and Pathology,1 Animal Reproduction and Biotechnology Laboratory, Equine Center, Colorado State University, Fort Collins, Colorado 80523,2 Department of Microbiology and Parasitology, The University of Queensland, St. Lucia, Queensland, Australia 4072,3 Division of Vector-Borne Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 80522,4 Office of the Surgeon General, United States Air Force, Washington, D.C. 203325

Received 5 February 2003/ Returned for modification 16 March 2003/ Accepted 26 March 2003


arrow
ABSTRACT
 
We evaluated the ability of epitope-blocking enzyme-linked immunosorbent assays (ELISAs) to detect West Nile virus (WNV) antibodies in domestic mammals. Sera were collected from experimentally infected horses, cats, and pigs at regular intervals and screened in ELISAs and plaque reduction neutralization tests. The diagnostic efficacies of these techniques were similar.


arrow
TEXT
 
West Nile virus (WNV) is a single-stranded, positive-sense RNA virus in the genus Flavivirus, family Flaviviridae (3). It is a member of the Japanese encephalitis virus (JEV) complex, which also includes JEV, St. Louis encephalitis virus (SLEV), Murray Valley encephalitis virus, and Koutango virus (KOUV) (12). WNV is transmitted in natural cycles between mosquitoes and birds, and humans and horses are incidental hosts (11). WNV has a wide geographic distribution, recently including North America. The initial outbreak of WNV in North America took place in New York in 1999, with mortality observed in humans, horses, and numerous species of wild birds (6, 8, 15). WNV activity has now been detected throughout most of the United States, and clinical infections in thousands of humans and horses have been reported. WNV is known to infect many other mammals, including cats, dogs, donkeys, goats, sheep, pigs, cows, rabbits, squirrels, and bats (7, 11, 13).

Serologic diagnosis of WNV infections in vertebrates can be achieved by the plaque reduction neutralization test (PRNT) and the hemagglutination inhibition assay (1). However, these assays are laborious and therefore not ideal for large-scale routine testing of sera. In contrast, enzyme-linked immunosorbent assays (ELISAs) provide rapid diagnostic and surveillance techniques to monitor WNV activity. We have previously reported the application of epitope-blocking ELISAs for the detection of WNV antibodies in multiple avian species (2, 9). Here, the ability of the blocking ELISAs to detect WNV antibodies in selected species of domestic mammals was evaluated.

Protocols used to prepare ELISA coating antigen and perform blocking ELISAs have been described previously (2). Five monoclonal antibodies (MAbs) were tested in blocking assays, and the production and characterization of these MAbs have been described elsewhere (10, 16, 17). Briefly, MAb 2B2 is WNV and KOUV specific, MAb 3.1112G is WNV specific, MAb 6B5A-2 is SLEV specific, and MAbs 3H6 and 6B6C-1 are flavivirus group reactive. All MAbs detect E protein epitopes, with the exception of MAb 3.1112G, which detects an NS1 epitope. MAb 6B6C-1 was labeled with horseradish peroxidase; all other MAbs were unlabeled. To calculate the percent inhibition of MAb binding in blocking assays, the following formula was used: 100 - [(TS - B)/(CS - B)] x 100. TS denotes the optical density (OD) of the test sample, CS denote the OD of the control serum, and B denotes the background OD. Previously, an inhibition value >=30% was shown to indicate the presence of viral antibodies in avian sera (2), and the same diagnostic criterion was used here.

Nine horses (H1 to H9), four cats (C1 to C4), and four pigs (P1 to P4) were experimentally inoculated with WNV (NY-99) via infected Aedes albopictus mosquitoes. Prior to inoculation, all animals were screened by PRNT for neutralizing antibodies against WNV and SLEV and were shown to be negative. Animals were then relocated to a BL-3 containment facility, where virus inoculations were performed. Horses were sampled at 7, 14, 21, and 28 days postinfection (p.i.), unless they were euthanized earlier. Cats were sampled at 7, 14, and 28 days p.i., and pigs were sampled at 7, 14, and 21 days p.i. Animals were also bled immediately before inoculation (0 days p.i.). These animals are being used in WNV experimental infection trials. Details of that study, including the viremia profile and course of clinical disease (if any) of each animal, will be presented elsewhere (D. R. Bowen, unpublished data). Serum was obtained from an additional horse (H10) that was immunized with a recombinant DNA vaccine expressing the WNV prM and E genes prior to WNV challenge (5). Fifteen weeks postimmunization, the horse was challenged with WNV via infected A. albopictus mosquitoes, and serum was collected 31 days later.

First, the ability of the blocking ELISA to detect antibodies in the nonvaccinated WNV-infected horses was evaluated. Most-promising results were obtained in assays utilizing MAbs 3.1112G and 6B6C-1, with antibodies detected in all sera collected at >=14 days p.i. (Table 1). These findings correlated well with the PRNT data. That is, all sera exhibiting neutralizing titers at a 90% plaque reduction level (PRNT90) were positive in ELISAs. For MAb 3.1112G, the mean inhibition values for sera collected at 14, 21, and 28 days p.i. were 55.6, 67.9, and 75.4%, respectively. For MAb 6B6C-1, the mean inhibition values for sera collected at 14, 21, and 28 days p.i. were 53.1, 63.5, and 70.0%, respectively. ELISAs that utilized MAbs 2B2 and 3H6 were also effective, with antibodies detected in most horses at 14 days p.i. and in all horses at >=21 days p.i. Serum from the vaccinated horse was positive in all assays using E-specific MAbs, revealing that the horse had generated an immune response prior to WNV challenge (Table 1). In contrast, the serum was negative in the ELISA that utilized MAb 3.1112G. However, the inhibition value was just below the diagnostic criterion, suggesting that a limited amount of MAb-binding inhibition occurred. It is possible that vaccination did not provide sterile immunity and that a low level of WNV replication occurred after challenge.


View this table:
[in this window]
[in a new window]
  		TABLE 1. Percent inhibition of MAbs by blocking ELISA using sera from WNV-infected horsesc

All PRNT90-positive cat sera were positive in blocking assays that utilized MAbs 3H6 and 6B6C-1 (Table 2). ELISAs using these MAbs also detected antibodies in two PRNT90-negative sera. However, both sera exhibited low PRNT titers at a plaque reduction level of 80% (data not shown). Assays using MAbs 3.1112G and 2B2 were also effective, with antibodies detected in three and four cats, respectively, at 21 days p.i. Analysis of the pig sera revealed that all specimens collected at 28 days p.i. were positive in ELISAs utilizing MAbs 3.1112G and 6B6C-1, while three were positive in assays using MAbs 2B2 and 3H6 (Table 2). In contrast, only two sera collected on day 28 were PRNT90 positive, although one of the PRNT90-negative samples exhibited a low PRNT80 titer (data not shown). All PRNT90-positive pig sera collected at 14 days p.i. were positive in assays using MAb 6B6C-1, while the two PRNT90-positive sera collected at 7 days p.i. were negative in all assays.


View this table:
[in this window]
[in a new window]
  		TABLE 2. Percent inhibition of MAbs by blocking ELISA using sera from WNV-infected cats and pigs and SLEV-infected cowsd

To further validate the diagnostic efficacy of the blocking ELISAs, sera from five SLEV-infected cows (CO1 to CO5) were tested. Specimens were collected from domestic cows during a serological survey in Chiapas, Mexico, in 2001. All sera contained detectable levels of neutralizing antibodies against SLEV (Table 2). Antibodies were detected in four cows in assays using the flavivirus group-reactive MAbs 3H6 and 6B6C-1 and in three cows with the SLEV type-specific MAb 6B5A-2. All sera were negative when the WNV MAbs, 2B2 and 3.1112G, were used. One serum sample failed to block MAb binding in all assays.

The ability of the blocking-ELISA technique to detect antibodies against various other flaviviruses of the Americas was determined. Hyperimmune mouse ascitic fluids (HIMAFs) containing antibodies against WNV, SLEV, Ilheus virus (ILHV), Bussuquara virus (BSQV), or Powassan virus (POWV) were tested in ELISAs using MAb 6B6C-1. All HIMAFs significantly inhibited MAb binding. The inhibition values were 58.9% for the WNV HIMAF, 70.9% for the SLEV HIMAF, 68.1% for the ILHV HIMAF, 38.7% for the BSQV HIMAF, and 60.2% for the POWV HIMAF. The ability to detect POWV antibodies is of particular interest, as phylogenetic studies have shown that the tick-borne and mosquito-borne flaviviruses are evolutionarily diverse and separated into two distinct clades (3). Therefore, this assay can potentially be exploited to identify antibodies against many different flaviviruses. Serum from an uninfected mouse was used as control serum when calculating the percentages of inhibition.

To ascertain the sensitivity of the ELISAs, 15 randomly selected samples were tested at multiple dilutions against MAbs 3.1112G and 6B6C-1. Sera were serially twofold diluted by using a starting dilution of 1:10, and HIMAFs were serially twofold diluted by using a starting dilution of 1:5,000. Both MAbs worked particularly well when used to screen sera from nonvaccinated horses. The six specimens tested exhibited ELISA end point titers between 80 and 320 (Table 3). In assays that utilized MAb 6B6C-1, all cat, pig, and cow sera tested displayed ELISA end point titers >=160. The WNV and SLEV HIMAFs significantly inhibited the binding of MAb 6B6C-1 at dilutions >=40,000.


View this table:
[in this window]
[in a new window]
  		TABLE 3. Determination of antibody titers in sera and ascitic fluids by blocking ELISA

Therefore, the blocking ELISA reliably detected flavivirus antibodies in several evolutionarily diverse species of mammals. Indeed, similar assays have been exploited to detect serum antibodies against WNV (subtype Kunjin virus) in laboratory-infected rabbits (9). The present study demonstrated the concordance of ELISA and PRNT. Occasional disparities were observed, but this was not unexpected because the two assays do not necessarily detect the same antibody types. Furthermore, neutralizing antibodies have a greater longevity than nonneutralizing antibodies (4), and this may explain why one cow tested negative by ELISA. Comparative analyses of immunoglobulin M antibody capture ELISAs and PRNTs revealed occasional discrepancies in arbovirus diagnosis (14). However, blocking ELISAs provide a more rapid and less expensive means to detect WNV infections than PRNTs, so these assays would greatly facilitate WNV surveillance studies in the United States.


arrow
ACKNOWLEDGMENTS
 
This study was supported by grant U50 CCU820510 from the Centers for Disease Control and Prevention.

We thank Nicholas Komar, Stanley Langevin, and Armando Ulloa for providing the cow sera.


arrow
FOOTNOTES
 
* Corresponding author. Mailing address: Arthropod-Borne and Infectious Diseases Laboratory, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523. Phone: (970) 491-2988. Fax: (970) 491-8323. E-mail: bbeaty{at}colostate.edu. Back


arrow
REFERENCES
 
    1
  1. Beaty, B. J., C. H. Calisher, and R. E. Shope. 1989. Arboviruses, p. 797-855. In N. J. Schmidt and R. W. Emmons (ed.), Diagnostic procedures for viral, rickettsial, and chlamydial infections, 6th ed. American Public Health Association, Washington, D.C.
    2. 2
  2. Blitvich, B. J., N. L. Marlenee, R. A. Hall, C. H. Calisher, R. A. Bowen, J. T. Roehrig, N. Komar, S. A. Langevin, and B. J. Beaty. 2003. Epitope-blocking enzyme-linked immunosorbent assays for detection of serum antibodies to West Nile virus in multiple avian species. J. Clin. Microbiol. 41:1041-1047.[Abstract/Free Full Text]
    3. 3
  3. Burke, D. S., and T. P. Monath. 2001. Flaviviruses, p. 1043-1126. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams and Wilkins, Philadelphia, Pa.
    4. 4
  4. Casals, J. 1973. Arbovirus infections, p. 99-117. In J. R. Paul, and C. White (ed.), Serological epidemiology. Academic Press, New York, N.Y.
    5. 5
  5. Davis, B. S., G.-J. J. Chang, B. Cropp, J. T. Roehrig, D. A. Martin, C. J. Mitchell, R. Bowen, and M. L. Bunning. 2001. West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays. J. Virol. 75:4040-4047.[Abstract/Free Full Text]
    6. 6
  6. Eidson, M., N. Komar, F. Sorhage, R. Nelson, T. Talbot, F. Mostashari, and R. McLean. 2001. Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999. Emerg. Infect. Dis. 7:615-620.[Medline]
    7. 7
  7. Garmendia, A. E., H. J. Van Kruiningen, and R. A. French. 2001. The West Nile virus: its recent emergence in North America. Microbes Infect. 3:223-229.[CrossRef][Medline]
    8. 8
  8. Gubler, D. J., G. L. Campbell, R. Nasci, N. Komar, L. Petersen, and J. T. Roehrig. 2000. West Nile virus in the United States: guidelines for detection, prevention, and control. Viral Immunol. 13:469-475.[Medline]
    9. 9
  9. Hall, R. A., A. K. Broom, A. C. Hartnett, M. J. Howard, and J. S. Mackenzie. 1995. Immunodominant epitopes on the NS1 protein of MVE and KUN viruses serve as targets for a blocking ELISA to detect virus-specific antibodies in sentinel animal serum. J. Virol. Methods 51:201-210.[CrossRef][Medline]
    10. 10
  10. Hall, R. A., B. H. Kay, G. W. Burgess, P. Clancy, and I. D. Fanning. 1990. Epitope analysis of the envelope and non-structural glycoproteins of Murray Valley encephalitis virus. J. Gen. Virol. 71:2923-2930.[Abstract/Free Full Text]
    11. 11
  11. Hayes, C. G. 1988. West Nile fever, p. 59-88. In T. P. Monath (ed.), The arboviruses: epidemiology and ecology. CRC Press Inc., Boca Raton, Fla.
    12. 12
  12. Heinz, F. X., M. S. Collett, R. H. Purcell, E. A. Gould, C. R. Howard, M. Houghton, R. J. M. Moormann, C. M. Rice, and H.-J. Theil. 2000. Family Flaviviridae, p 859-878. In M. H. V. van Regenmortel, C. M. Fauquet, D. H. L. Bishop, E. B. Carstens, M. K. Estes, S. M. Lemon, J. Maniloff, M. A. Mayo, D. J. McGeoch, C. R. Pringle, and R. B. Wickner (ed.), Virus taxonomy. Seventh report of the International Committee for the Taxonomy of Viruses. Academic Press, San Diego, Calif.
    13. 13
  13. Komar, N. 2000. West Nile viral encephalitis. Rev. Sci. Technol. 19:166-176.[Medline]
    14. 14
  14. Martin, D. A., D. A. Muth, T. Brown, A. J. Johnson, N. Karabatsos, and J. T. Roehrig. 2000. Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J. Clin. Microbiol. 38:1823-1826.[Abstract/Free Full Text]
    15. 15
  15. Nash, D., F. Mostashari, A. Fine, J. Miller, D. O'Leary, K. Murray, A. Huang, A. Rosenberg, A. Greenberg, M. Sherman, S. Wong, and M. Layton. 2001. The outbreak of West Nile virus infection in the New York City area in 1999. N. Engl. J. Med. 344:1807-1814.[Abstract/Free Full Text]
    16. 16
  16. Roehrig, J. T., J. H. Mathews, and D. W. Trent. 1983. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology 128:118-126.[CrossRef][Medline]
    17. 17
  17. Scherret, J. H., M. Poidinger, J. S. Mackenzie, A. K. Broom, V. Deubel, W. I. Lipkin, T. Briese, E. A. Gould, and R. A. Hall. 2001. The relationships between West Nile and Kunjin viruses. Emerg. Infect. Dis. 7:697-705.[Medline]

Journal of Clinical Microbiology, June 2003, p. 2676-2679, Vol. 41, No. 6
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.6.2676-2679.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Blitvich, B. J., Juarez, L. I., Tucker, B. J., Rowley, W. A., Platt, K. B. (2009). Antibodies to West Nile Virus in Raccoons and Other Wild Peridomestic Mammals in Iowa. J Wildl Dis 45: 1163-1168 [Abstract] [Full Text]  
  • Lorono-Pino, M. A., Farfan-Ale, J. A., Blitvich, B. J., Beebe, J. L., Jarman, R. G., Beaty, B. J. (2009). Evaluation of an Epitope-Blocking Enzyme-Linked Immunosorbent Assay for the Diagnosis of West Nile Virus Infections in Humans. CVI 16: 749-755 [Abstract] [Full Text]  
  • Hobson-Peters, J., Toye, P., Sanchez, M. D., Bossart, K. N., Wang, L.-F., Clark, D. C., Cheah, W. Y., Hall, R. A. (2008). A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection. J. Gen. Virol. 89: 3063-3072 [Abstract] [Full Text]  
  • ROOT, J. J., OESTERLE, P. T., SULLIVAN, H. J., HALL, J. S., MARLENEE, N. L., MCLEAN, R. G., MONTENIERI, J. A., CLARK, L. (2007). FOX SQUIRREL (SCIURUS NIGER) ASSOCIATIONS WITH WEST NILE VIRUS. Am J Trop Med Hyg 76: 782-784 [Abstract] [Full Text]  
  • BENTLER, K. T., HALL, J. S., ROOT, J. J., KLENK, K., SCHMIT, B., BLACKWELL, B. F., RAMEY, P. C., CLARK, L. (2007). SEROLOGIC EVIDENCE OF WEST NILE VIRUS EXPOSURE IN NORTH AMERICAN MESOPREDATORS. Am J Trop Med Hyg 76: 173-179 [Abstract] [Full Text]  
  • Sondgeroth, K., Blitvich, B., Blair, C., Terwee, J., Junge, R., Sauther, M., VandeWoude, S. (2007). ASSESSING FLAVIVIRUS, LENTIVIRUS, AND HERPESVIRUS EXPOSURE IN FREE-RANGING RING-TAILED LEMURS IN SOUTHWESTERN MADAGASCAR. J Wildl Dis 43: 40-47 [Abstract] [Full Text]  
  • ROOT, J. J., OESTERLE, P. T., NEMETH, N. M., KLENK, K., GOULD, D. H., MCLEAN, R. G., CLARK, L., HALL, J. S. (2006). Experimental infection of fox squirrels (sciurus niger) with west nile virus.. Am J Trop Med Hyg 75: 697-701 [Abstract] [Full Text]  
  • Oliveira, N. M. M., Broom, A. K., Mackenzie, J. S., Smith, D. W., Lindsay, M. D. A., Kay, B. H., Hall, R. A. (2006). Epitope-Blocking Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Ross River Virus in Vertebrate Sera.. CVI 13: 814-817 [Abstract] [Full Text]  
  • Hukkanen, R. R., Liggitt, H. D., Kelley, S. T., Grant, R., Anderson, D. M., Hall, R. A., Tesh, R. B., Travassos DaRosa, A. P., Bielefeldt-Ohmann, H. (2006). West Nile and St. Louis Encephalitis Virus Antibody Seroconversion, Prevalence, and Persistence in Naturally Infected Pig-Tailed Macaques (Macaca nemestrina). CVI 13: 711-714 [Abstract] [Full Text]  
  • FARFAN-ALE, J. A., BLITVICH, B. J., MARLENEE, N. L., LORONO-PINO, M. A., PUERTO-MANZANO, F., GARCIA-REJON, J. E., ROSADO-PAREDES, E. P., FLORES-FLORES, L. F., ORTEGA-SALAZAR, A., CHAVEZ-MEDINA, J., CREMIEUX-GRIMALDI, J. C., CORREA-MORALES, F., HERNANDEZ-GAONA, G., MENDEZ-GALVAN, J. F., BEATY, B. J. (2006). ANTIBODIES TO WEST NILE VIRUS IN ASYMPTOMATIC MAMMALS, BIRDS, AND REPTILES IN THE YUCATAN PENINSULA OF MEXICO.. Am J Trop Med Hyg 74: 908-914 [Abstract] [Full Text]  
  • BEVEROTH, T. A., WARD, M. P., LAMPMAN, R. L., RINGIA, A. M., NOVAK, R. J. (2006). CHANGES IN SEROPREVALENCE OF WEST NILE VIRUS ACROSS ILLINOIS IN FREE-RANGING BIRDS FROM 2001 THROUGH 2004. Am J Trop Med Hyg 74: 174-179 [Abstract] [Full Text]  
  • WANG, E., PAESSLER, S., AGUILAR, P. V., SMITH, D. R., COFFEY, L. L., KANG, W., PFEFFER, M., OLSON, J., BLAIR, P. J., GUEVARA, C., ESTRADA-FRANCO, J., WEAVER, S. C. (2005). A NOVEL, RAPID ASSAY FOR DETECTION AND DIFFERENTIATION OF SEROTYPE-SPECIFIC ANTIBODIES TO VENEZUELAN EQUINE ENCEPHALITIS COMPLEX ALPHAVIRUSES. Am J Trop Med Hyg 72: 805-810 [Abstract] [Full Text]  
  • ROOT, J. J., HALL, J. S., MCLEAN, R. G., MARLENEE, N. L., BEATY, B. J., GANSOWSKI, J., CLARK, L. (2005). SEROLOGIC EVIDENCE OF EXPOSURE OF WILD MAMMALS TO FLAVIVIRUSES IN THE CENTRAL AND EASTERN UNITED STATES. Am J Trop Med Hyg 72: 622-630 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Blitvich, B. J.
Right arrow Articles by Beaty, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blitvich, B. J.
Right arrow Articles by Beaty, B. J.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»